Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11539 |
HCV-IN-29
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
HCV-IN-29 是一种丙型肝炎病毒抑制剂。 | |||
T11540 |
HCV-IN-3
|
Others | Others |
HCV-IN-3 is a hepatitis C virus (HCV) NS3/4a protein inhibitor (IC50: 20 μM; Kd: 29 μM). | |||
T36882 |
CAY10773
|
||
CAY10773 is a derivative of the ferroptosis inducer sorafenib .1It selectively inhibits proliferation of BEL-7402, MGC803, and T24 bladder cancer cells (IC50s = 5.77, 5.21 and 3.97 μM, respectively) over non-cancerous HCV-29 cells (IC50= 23.19 μM). CAY10773 induces apoptosis in T24 cells when used at concentrations ranging from 2 to 6 μM but induces ferroptosis at concentrations greater than or equal to 6 μM with 10 hour or longer incubation times. It increases the production of reactive oxygen ... |